We recently posted that we were bringing the CiteAb awards back again this winter with a host of new categories in addition to some you have seen before.

Today, product manager Alicia Cooper talks us through changes to the awards and the categories that we plan to have this year.

“In previous years we’ve always had a split between awards that are open for nomination and those made based on CiteAb data taken from the analysis of citations, and we’re going to maintain that this year but with some changes.

“We have eight awards based on CiteAb data, and four which will be open for nomination. Nominations will open through a dedicated awards website, which we’ll promote here on our blog and link to from the CiteAb homepage, from the end of November.

“All nominations will need to be made before midnight (GMT) on Friday 19th January, with our judges making their decisions over the following week ahead of an announcement revealing winners on Monday 29th January.

The categories for this years awards made based on CiteAb data will be:

  • Antibody company of the year
    Recognition of the company with the most antibody citations based on data gathered between January 2017 and December 2017. Previous winners in this category include Abcam (2017) and Cell Signalling Technology (2016).
  • Chemical probes company of the year
    A new category and one that has been created in recognition of CiteAb’s new technology that allows the collation of data on multiple reagent types – not just antibodies. This award will be based on citation data gathered between January 2017 and December 2017.
  • Antibody supplier to watch in 2018
    An exciting award that looks at growth trajectories, recognising the company with the largest percentage increase in citations based on data gathered between January 2017 and December 2017. Past winners include Tonbo Biosciences (2017) and Boster Immunoleader (2016).
  • Chemical probes supplier to watch in 2018
    Another new category, recognising the chemical probes company with the largest percentage increase in citations based on data gathered between January 2017 and December 2017.
  • Antibody company succeeding in cancer biology
    This new research category award will recognise the company with the most citations achieved in the cancer biology market between January 2017 and December 2017.
  • Antibody company with sustained success in China
    This award recognises the antibody company which has achieved the largest increase in antibody market share over the past five years. The award will be made based on citation data from 2013 – 2017.
  • Flow cytometer of the year
    This new award will look at the data for the most cited flow cytometer instrument between January 2017 and December 2017, recognising the instrument most succeeding in this market.
  • Custom antibody supplier of the year
    Previously an award that was open to nomination, our team has decided to keep this category but to make the award based on citation data this year. The award will go to the company that has secured the most custom antibody citations between January 2017 and December 2017.

The categories for this years awards made based on nominations will be:

  • Innovative product of the year
    This brand new award gives you an opportunity to put the spotlight on products you’ve been working on or have used that are set to change the sector. This could be a reagent or an instrument, ‘product’ can be interpreted broadly, although our judges will look for evidence that the product you’re nominating has filled a gap in the market or provided an innovative solution to a known issue. You can self-nominate in this category, or nominate a company that has impressed you.
  • Researchers’ choice
    An award we have run in previous years (previously won by Cell Signaling Technology) which returns by popular demand, but now focused not just on antibodies but on all reagent suppliers. This category really sheds light on how well companies are performing by going to the customer, the researchers using reagents, to ask them which supplier has most impressed them. Nominees must be researchers who have used their nominated supplier between January 2017 and December 2017, and can provide judges with information about why the experience they had was award-worthy.
  • Lifetime achievement award
    There are always a small number of individuals in a sector who make an outstanding impact, and this award recognises those unique efforts. Past winners of this award have included Karen Padgett (2017) and Dr Jonathan Milner (2016). This award is only open to third party nominations, so if there is someone you feel the sector should honour, then do make a submission!
  • Antibody validation initiative
    As you’ll know, the CiteAb team are all very passionate about validation, making this award one that is possibly our favourite. Judges will accept self-nomination or third party nomination in this category, and will be looking for the most exciting new initiatives in the sector. Past winners have included Abcam’s Knockout validation initiative in 2017, and Proteintech’s RNA interference (RNAi) technology in 2016. Most work on the initiative nominated should have been completed between January 2017 and December 2017.

“Having joined CiteAb over the summer, this is my first experience of being involved in the awards. I’ve heard a lot about the really impressive work that past winners have put forward and am looking forward to seeing the spotlight shone on equally interesting projects this year. The awards are a great way to showcase the fantastic achievements, initiatives and progress being made across the sector, of sharing best practice and of demonstrating the innovative nature of bioscience companies.

“If anyone has any questions about the awards I’d be more than happy to help out, just get in touch. In the meantime, good luck to all of you who nominate!”

– Alicia and the CiteAb team